IgG4-related sclerosing disease a critical appraisal of an evolving clinicopathologic entity

Advances in Anatomic Pathology

Volumn 17, Issue 5, 2010, Pages 303-332

  Cheuk, Wah ^a   Chan, John K C ^a  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

Autoimmune pancreatitis; IgG4 related disease; IgG4 related sclerosing disease; Inflammatory fibrosclerosing lesion; Inflammatory pseudotumor; Lymphadeno pathy; Pseudolymphoma; Sclerosing cholangitis

Indexed keywords

ANTINUCLEAR ANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; LACTATE DEHYDROGENASE; RHEUMATOID FACTOR;

ADENOCARCINOMA; AGED; AORTA; AUTOIMMUNE PANCREATITIS; BILE DUCT; BREAST; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; GALLBLADDER; GASTROINTESTINAL CARCINOMA; HUMAN; HYPERPLASIA; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; KIDNEY; LACRIMAL GLAND; LIVER; LUNG; LUNG ADENOCARCINOMA; LYMPH NODE; LYMPHADENOPATHY; LYMPHOMA; MAXILLARY SINUS; MEDIASTINUM; MESENTERY; MORPHOLOGY; NOSE SEPTUM; OBSTRUCTIVE JAUNDICE; ORBIT; PARANASAL SINUS; PATHOGENESIS; PERICARDIUM; PHLEBITIS; PLEURA; PRIORITY JOURNAL; PROSTATE; PSEUDOLYMPHOMA; RETROPERITONEUM; REVIEW; RHEUMATOID ARTHRITIS; ROSAI DORFMAN DISEASE; SALIVARY GLAND; SALIVARY GLAND DUCT; SCLEROSING CHOLANGITIS; SCLEROSIS; SEMINAL VESICLE; SJOEGREN SYNDROME; SKIN; THYROID GLAND; URINARY TRACT;

AGED; AUTOIMMUNE DISEASES; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; PANCREATITIS; SCLEROSIS;

EID: 78049488590     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/PAP.0b013e3181ee63ce     Document Type: Review

References (213)

1. Grey HM, Kunkel HG. H chain subgroups of myeloma proteins and normal 7s gamma-globulin. J Exp Med. 1964; 120:253-266.
2. Spiegelberg HL. Biological activities of immunoglobulins of different classes and subclasses. Adv Immunol. 1974;19: 259-294.
3. van der Zee JS, van Swieten P, Aalberse RC. Inhibition of complement activation by IgG4 antibodies. Clin Exp Immunol. 1986;64:415-422.
4. Shakib F. The IgG4 subclass. Monogr Allergy. 1986;19: 223-226.
5. Jones CC, Hamilton RG, Jordon RE. Subclass distribution of human IgG autoantibodies in pemphigus. J Clin Immunol. 1988;8:43-49.
6. Futei Y, Amagai M, Ishii K, et al. Predominant IgG4 subclass in autoantibodies of pemphigus vulgaris and foliaceus. J Dermatol Sci. 2001;26:55-61.
7. Hawrylowicz CM, O'Garra A. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat Rev Immunol. 2005;5:271-283.
8. Hussain R, Poindexter RW, Ottesen EA. Control of allergic reactivity in human filariasis. Predominant localization of blocking antibody to the IgG4 subclass. J Immunol. 1992;148: 2731-2737.
9. Sarles H, Sarles JC, Muratore R, et al. Chronic inflammatory sclerosis of the pancreas - an autonomous pancreatic disease? Am J Dig Dis. 1961;6:688-698.
10. Yoshida K, Toki F, Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995;40: 1561-1568.
11. Okazaki K, Chiba T. Autoimmune related pancreatitis. Gut. 2002;51:1-4.
12. Zamboni G, Luttges J, Capelli P, et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch. 2004;445:552-563.
13. Aparisi L, Farre A, Gomez-Cambronero L, et al. Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis. Gut. 2005;54:703-709.
14. Okazaki K, Uchida K, Ohana M, et al. Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology. 2000;118: 573-581.
15. Deshpande V, Mino-Kenudson M, Brugge W, et al. Autoimmune pancreatitis: more than just a pancreatic disease? A contemporary review of its pathology. Arch Pathol Lab Med. 2005;129:1148-1154.
16. Kamisawa T, Okamoto A. Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J Gastroenterol. 2006; 41:613-625. (Pubitemid 44288524)
17. Kawa S, Ota M, Yoshizawa K, et al. HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population. Gastroenterology. 2002; 122:1264-1269.
18. Uchida K, Okazaki K, Nishi T, et al. Experimental immune-mediated pancreatitis in neonatally thymectomized mice immunized with carbonic anhydrase II and lactoferrin. Lab Invest. 2002;82:411-424.
19. Davidson TS, Longnecker DS, Hickey WF. An experimental model of autoimmune pancreatitis in the rat. Am J Pathol. 2005;166:729-736.
20. Kawaguchi K, Koike M, Tsuruta K, et al. Lymphoplasma-cytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol. 1991;22:387-395.
21. Ectors N, Maillet B, Aerts R, et al. Non-alcoholic duct destructive chronic pancreatitis. Gut. 1997;41:263-268.
22. Sood S, Fossard DP, Shorrock K. Chronic sclerosing pancreatitis in Sjogren's syndrome: a case report. Pancreas. 1995;10:419-421.
23. Kodama T, Abe M, Sato H, et al. A case of pseudotumorous pancreatitis that presented unique pancreatoscopic findings with the peroral electronic pancreatoscope. J Gastroenterol Hepatol. 2003;18:108-111.
24. Yadav D, Notahara K, Smyrk TC, et al. Idiopathic tumefactive chronic pancreatitis: clinical profile, histology, and natural history after resection. Clin Gastroenterol Hepatol. 2003;1:129-135.
25. Wakabayashi T, Kawaura Y, Satomura Y, et al. Long-term prognosis of duct-narrowing chronic pancreatitis: strategy for steroid treatment. Pancreas. 2005;30:31-39.
26. Notohara K, Burgart LJ, Yadav D, et al. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol. 2003;27:1119-1127.
27. Sah RP, Chari ST, Pannala R, et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology. 2010;139:140-148.
28. Sugumar A, Kloppel G, Chari ST. Autoimmune pancreatitis: pathologic subtypes and their implications for its diagnosis. Am J Gastroenterol. 2009;104:2308-2310; quiz 2311.
29. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732-738.
30. Kamisawa T. IgG4-positive plasma cells specifically infiltrate various organs in autoimmune pancreatitis. Pancreas. 2004; 29:167-168.
31. Kojima M, Sipos B, Klapper W, et al. Autoimmune pancreatitis: frequency, IgG4 expression, and clonality of T and B cells. Am J Surg Pathol. 2007;31:521-528.
32. Deshpande V, Chicano S, Finkelberg D, et al. Autoimmune pancreatitis: a systemic immune complex mediated disease. Am J Surg Pathol. 2006;30:1537-1545.
33. Zhang L, Notohara K, Levy MJ, et al. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol. 2007;20:23-28.
34. Sepehr A, Mino-Kenudson M, Ogawa F, et al. IgG4+ to IgG+ plasma cells ratio of ampulla can help differentiate autoimmune pancreatitis from other "mass forming" pancreatic lesions. Am J Surg Pathol. 2008;32:1770-1779.
35. Kamisawa T, Yoshiike M, Egawa N, et al. Chronic pancreatitis in the elderly in Japan. Pancreatology. 2004;4: 223-227; discussion 227-228.
36. Kim KP, Kim MH, Song MH, et al. Autoimmune chronic pancreatitis. Am J Gastroenterol. 2004;99:1605-1616.
37. Nishimori I, Tamakoshi A, Otsuki M. Prevalence of autoimmune pancreatitis in Japan from a nationwide survey in 2002. J Gastroenterol. 2007;42(suppl 18):6-8.
38. Pearson RK, Longnecker DS, Chari ST, et al. Controversies in clinical pancreatology: autoimmune pancreatitis: does it exist? Pancreas. 2003;27:1-13.
39. Hardacre JM, Iacobuzio-Donahue CA, Sohn TA, et al. Results of pancreaticoduodenectomy for lymphoplasmacytic sclerosing pancreatitis. Ann Surg. 2003;237:853-858; discussion 858-859.
40. Abraham SC, Wilentz RE, Yeo CJ, et al. Pancreaticoduodenectomy (Whipple resections) in patients without malignancy: are they all "chronic pancreatitis"? Am J Surg Pathol. 2003; 27:110-120.
41. Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol. 2006;4:1010-1016; quiz 934.
42. Otsuki M, Chung JB, Okazaki K, et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J Gastro-enterol. 2008;43:403-408.
43. Khosroshahi A, Bloch DB, Deshpande V, et al. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum. 2010;62:1755-1762.
44. Suda K, Nishimori I, Takase M, et al. Autoimmune pancreatitis can be classified into early and advanced stages. Pancreas. 2006;33:345-350.
45. Zen Y, Harada K, Sasaki M, et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudo-tumor, and sclerosing pancreatitis-associated sclerosing cho-langitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol. 2004;28:1193-1203.
46. Ito T, Nishimori I, Inoue N, et al. Treatment for autoimmune pancreatitis: consensus on the treatment for patients with autoimmune pancreatitis in Japan. J Gastroenterol. 2007; 42(suppl 18):50-58. (Pubitemid 46863938)
47. Dhall D, Suriawinata AA, Tang LH, et al. Use of immunohistochemistry for IgG4 in the distinction of autoimmune pancreatitis from peritumoral pancreatitis. Hum Pathol. 2010;41:643-652.
48. Hamano H, Arakura N, Muraki T, et al. Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol. 2006;41:1197-1205.
49. Kamisawa T, Okamoto A, Funata N. Clinicopathological features of autoimmune pancreatitis in relation to elevation of serum IgG4. Pancreas. 2005;31:28-31.
50. Raina A, Krasinskas AM, Greer JB, et al. Serum immuno-globulin G fraction 4 levels in pancreatic cancer: elevations not associated with autoimmune pancreatitis. Arch Pathol Lab Med. 2008;132:48-53.
51. Ghazale A, Chari ST, Smyrk TC, et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol. 2007; 102:1646-1653.
52. Kitagawa S, Zen Y, Harada K, et al. Abundant IgG4-positive plasma cell infiltration characterizes chronic sclerosing sialadenitis (Kuttner's tumor). Am J Surg Pathol. 2005;29: 783-791.
53. Wang WL, Farris AB, Lauwers GY, et al. Autoimmune pancreatitis-related cholecystitis: a morphologically and immunologically distinctive form of lymphoplasmacytic sclerosing cholecystitis. Histopathology. 2009;54:829-836.
54. Chandan VS, Iacobuzio-Donahue C, Abraham SC. Patchy distribution of pathologic abnormalities in autoimmune pancreatitis: implications for preoperative diagnosis. Am J Surg Pathol. 2008;32:1762-1769.
55. Aguilar CE, Bucobo JC, Boulay B, et al. Does IgG4 immunostain on endoscopic biliary and ampullary biopsies predict the likelihood of autoimmune pancreatitis? (Abstr). Mod Pathol. 2010;23(suppl 1):135A.
56. Moon SH, Kim MH, Park DH, et al. IgG4 immunostaining of duodenal papillary biopsy specimens may be useful for supporting a diagnosis of autoimmune pancreatitis. Gastrointest Endosc. 2010;71:960-966.
57. Society MotCCfAPotJP. Diagnostic criteria for autoimmune pancreatitis by the Japan Pancreas Society. J Jpn Pancreas Soc. 2002;17:585-587.
58. Okazaki K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. Gastroenterol. 2006;41:626-631.
59. Kim KP, Kim MH, Kim JC, et al. Diagnostic criteria for autoimmune chronic pancreatitis revisited. World J Gastroenterol. 2006;12:2487-2496.
60. Sato Y, Ohshima K, Ichimura K, et al. Ocular adnexal IgG4-related disease has uniform clinicopathology. Pathol Int.2008;58:465-470.
61. Cheuk W, Chan JK. Lymphoproliferative lesions in IgG4-related disease. Curr Immunol Rev. 2010. In press.
62. Geyer JT, Ferry JA, Harris NL, et al. Chronic sclerosing sialadenitis (Kuttner tumor) is an IgG4-associated disease. Am J Surg Pathol. 2010;34:202-210.
63. Zen Y, Sawazaki A, Miyayama S, et al. A case of retroperitoneal and mediastinal fibrosis exhibiting elevated levels of IgG4 in the absence of sclerosing pancreatitis (autoimmune pancreatitis). Hum Pathol. 2006;37:239-243.
64. Cheuk W, Lee KC, Chong LY, et al. IgG4-related sclerosing disease. A potential new etiology of cutaneous pseudolym-phoma. Am J Surg Pathol. 2009. In press.
65. Zen Y, Kitagawa S, Minato H, et al. IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Hum Pathol. 2005;36:710-717.
66. Cheuk W, Chan AC, Lam WL, et al. IgG4-related sclerosing mastitis: description of a new member of the IgG4-related sclerosing diseases. Am J Surg Pathol. 2009;33:1058-1064.
67. Cheuk W, Yuen HK, Chan JK. Chronic sclerosing dacryoa-denitis: part of the spectrum of IgG4-related Sclerosing disease? Am J Surg Pathol. 2007;31:643-645.
68. Cheuk W, Yuen HK, Chu SY, et al. Lymphadenopathy of IgG4-related sclerosing disease. Am J Surg Pathol. 2008;32: 671-681.
69. Chan SK, Cheuk W, Chan KT, et al. IgG4-related sclerosing pachymeningitis: a previously unrecognized form of central nervous system involvement in IgG4-related sclerosing disease. Am J Surg Pathol. 2009;33:1249-1252.
70. Kasashima S, Zen Y, Kawashima A, et al. Inflammatory abdominal aortic aneurysm: close relationship to IgG4-related periaortitis. Am J Surg Pathol. 2008;32:197-204.
71. Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 2003;38:982-984.
72. Kamisawa T, Funata N, Hayashi Y. Lymphoplasmacytic sclerosing pancreatitis is a pancreatic lesion of IgG4-related systemic disease. Am J Surg Pathol. 2004;28:1114.
73. Kamisawa T, Egawa N, Nakajima H. Autoimmune pancreatitis is a systemic autoimmune disease. Am J Gastroenterol. 2003;98:2811-2812.
74. Okazaki K, Uchida K, Chiba T. Recent concept of autoimmune-related pancreatitis. J Gastroenterol. 2001;36: 293-302.
75. Lara LP, Chari ST. Autoimmune pancreatitis. Curr Gastroenterol Rep. 2005;7:101-106.
76. Saeki T, Saito A, Hiura T, et al. Lymphoplasmacytic infiltration of multiple organs with immunoreactivity for IgG4: IgG4-related systemic disease. Intern Med. 2006;45: 163-167.
77. Shinji A, Sano K, Hamano H, et al. Autoimmune pancreatitis is closely associated with gastric ulcer presenting with abundant IgG4-bearing plasma cell infiltration. Gastrointest Endosc. 2004;59:506-511.
78. Akitake R, Watanabe T, Zaima C, et al. Possible involvement of T helper type 2 responses to Toll-like receptor ligands in IgG4-related sclerosing disease. Gut. 2010;59:542-545.
79. Kamisawa T. IgG4-related sclerosing disease. Intern Med. 2006;45:125-126.
80. Sato Y, Notohara K, Kojima M, et al. IgG4-related disease: historical overview and pathology of hematological disorders. Pathol Int. 2010;60:247-258.
81. Neild GH, Rodriguez-Justo M, Wall C, et al. Hyper-IgG4 disease: report and characterisation of a new disease. BMC Med. 2006;4:23.
82. Bateman AC, Deheragoda MG. IgG4-related systemic sclerosing disease-an emerging and under-diagnosed condition. Histopathology. 2009;55:373-383.
83. Kamisawa T, Nakajima H, Egawa N, et al. IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lympha-denopathy. Pancreatology. 2006;6:132-137.
84. Ghazale A, Chari ST, Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008;134:706-715.
85. Nakanuma Y, Zen Y. Pathology and immunopathology of immunoglobulin G4-related sclerosing cholangitis: the latest addition to the sclerosing cholangitis family. Hepatol Res. 2007;37(suppl 3):S478-S486.
86. Deshpande V, Sainani NI, Chung RT, et al. IgG4-associated cholangitis: a comparative histological and immunophenotypic study with primary sclerosing cholangitis on liver biopsy material. Mod Pathol. 2009;22:1287-1295.
87. Nakazawa T, Ohara H, Sano H, et al. Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis. Pancreas. 2005;30: 20-25.
88. Kawa S, Hamano H, Umemura T, et al. Sclerosing cholangitis associated with autoimmune pancreatitis. Hepatol Res. 2007;37(suppl 3):S487-S495.
89. Kamisawa T, Takuma K, Anjiki H, et al. Sclerosing cholangitis associated with autoimmune pancreatitis differs from primary sclerosing cholangitis. World J Gastroenterol. 2009;15:2357-2360.
90. Nakanuma Y, Harada K, Katayanagi K, et al. Definition and pathology of primary sclerosing cholangitis. J Hepatobiliary Pancreat Surg. 1999;6:333-342.
91. Erkelens GW, Vleggaar FP, Lesterhuis W, et al. Sclerosing pancreato-cholangitis responsive to steroid therapy. Lancet. 1999;354:43-44.
92. Nakazawa T, Ohara H, Yamada T, et al. Atypical primary sclerosing cholangitis cases associated with unusual pancreatitis. Hepatogastroenterology. 2001;48:625-630.
93. Kojima E, Kimura K, Noda Y, et al. Autoimmune pancreatitis and multiple bile duct strictures treated effectively with steroid. J Gastroenterol. 2003;38:603-607.
94. Kuroiwa T, Suda T, Takahashi T, et al. Bile duct involvement in a case of autoimmune pancreatitis successfully treated with an oral steroid. Dig Dis Sci. 2002;47:1810-1816.
95. Mendes FD, Jorgensen R, Keach J, et al. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol. 2006;101:2070-2075.
96. Webster GJ, Pereira SP, Chapman RW. Autoimmune pancreatitis/IgG4- associated cholangitis and primary sclerosing cholangitis - overlapping or separate diseases? J Hepatol. 2009;51:398-402.
97. Abraham SC, Cruz-Correa M, Argani P, et al. Lymphoplasmacytic chronic cholecystitis and biliary tract disease in patients with lymphoplasmacytic sclerosing pancreatitis. Am J Surg Pathol. 2003;27:441-451.
98. Jessurun J, Bolio-Solis A, Manivel JC. Diffuse lymphoplasmacytic acalculous cholecystitis: a distinctive form of chronic cholecystitis associated with primary sclerosing cholangitis. Hum Pathol. 1998;29:512-517.
99. Zen Y, Fujii T, Sato Y, et al. Pathological classification of hepatic inflammatory pseudotumor with respect to IgG4-related disease. Mod Pathol. 2007;20:884-894.
100. Kanno A, Satoh K, Kimura K, et al. Autoimmune pancreatitis with hepatic inflammatory pseudotumor. Pancreas. 2005;31:420-423.
101. Yamashita K, Haga H, Kobashi Y, et al. Lung involvement in IgG4-related lymphoplasmacytic vasculitis and interstitial fibrosis: report of 3 cases and review of the literature. Am J Surg Pathol. 2008;32:1620-1626.
102. Iwamuro M, Yamamoto K, Kawamoto H, et al. Eosinophilic cholangitis with initial clinical features indistinguishable from IgG4-related cholangitis. Intern Med. 2009;48:1143-1147.
103. Cheuk W, Chan JK, Shek TW, et al. Inflammatory pseudotumor-like follicular dendritic cell tumor: a distinctive low-grade malignant intra-abdominal neoplasm with consistent Epstein-Barr virus association. Am J Surg Pathol. 2001; 25:721-731.
104. Umemura T, Zen Y, Hamano H, et al. Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis. Hepatology. 2007;46:463-471.
105. Umemura T, Zen Y, Hamano H, et al. IgG4 associated autoimmune hepatitis: a differential diagnosis for classical autoimmune hepatitis. Gut. 2007;56:1471-1472.
106. Klepeis VE, Deshpande V, Sohani AR, et al. Sclerosing inflammatory pseudotumor of the orbit: an IgG4-related disease (Abstr). Mod Pathol. 2010;23(suppl 1):307A.
107. Chan JK. Kuttner tumor (chronic sclerosing sialadenitis) of the submandibular gland: an underrecognized entity. Adv Anat Pathol. 1998;5:239-251.
108. Cheuk W, Chan JK. Kuttner tumor of the submandibular gland: fine-needle aspiration cytologic findings of seven cases. Am J Clin Pathol. 2002;117:103-108.
109. Kamisawa T, Nakajima H, Hishima T. Close correlation between chronic sclerosing sialadenitis and immunoglobulin G4. Intern Med J. 2006;36:527-529.
110. Shah SS, Smyrk TC, Lewis JE. IgG4-positive plasma cell infiltrates in chronic sialadenitis involving submandibular glands (Abstr). Mod Pathol. 2010;23(suppl 1):280A.
111. Yamamoto M, Takahashi H, Ohara M, et al. A new conceptualization for Mikulicz's disease as an IgG4-related plasmacytic disease. Mod Rheumatol. 2006;16:335-340. (Pubitemid 44921578)
112. Yamamoto M, Takahashi H, Sugai S, et al. Clinical and pathological characteristics of Mikulicz's disease (IgG4-related plasmacytic exocrinopathy). Autoimmun Rev. 2005;4: 195-200. (Pubitemid 40704702)
113. Masaki Y, Dong L, Kurose N, et al. Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis. 2009;68:1310-1315.
114. Yamamoto H, Yamaguchi H, Aishima S, et al. Inflammatory myofibroblastic tumor versus IgG4-related sclerosing disease and inflammatory pseudotumor: a comparative clinicopathologic study. Am J Surg Pathol. 2009;33:1330-1340.
115. Comings DE, Skubi KB, Van Eyes J, et al. Familial multifocal fibrosclerosis. Findings suggesting that retroperitoneal fibrosis, mediastinal fibrosis, sclerosing cholangitis, Riedel's thyroiditis, and pseudotumor of the orbit may be different manifestations of a single disease. Ann Intern Med. 1967;66:884-892.
116. De Backer TL, Mollet P, Clement DL. Images in cardiology. Two brothers with mediastinal-retroperitoneal fibrosis. Clin Cardiol. 2001;24:633.
117. Klisnick A, Fourcade J, Ruivard M, et al. Combined idiopathic retroperitoneal and mediastinal fibrosis with pericardial involvement. Clin Nephrol. 1999;52:51-55.
118. Graal MB, Lustermans FA. A patient with combined mediastinal, mesenteric and retroperitoneal fibrosis. Neth J Med. 1994;44:214-219.
119. Stewart TW Jr, Friberg TR. Idiopathic retroperitoneal fibrosis with diffuse involvement: further evidence of systemic idiopathic fibrosis. South Med J. 1984;77:1185-1187.
120. Owen K, Lane H, Jones MK. Multifocal fibrosclerosis: a case of thyroiditis and bilateral lacrimal gland involvement. Thyroid. 2001;11:1187-1190.
121. Morris WR, Haik BG, Osborn D, et al. Intraocular involvement in multifocal fibrosclerosis. Ophthalmology. 2000;107:962-966.
122. Levey JM, Mathai J. Diffuse pancreatic fibrosis: an uncommon feature of multifocal idiopathic fibrosclerosis. Am J Gastroenterol. 1998;93:640-642.
123. Fukuda W, Kimura M, Akaogi T, et al. Multifocal fibrosclerosis: retroperitoneal fibrosis associated with a suprasellar tumor and pachymeningitis. Intern Med. 2003;42: 1006-1010.
124. Dehner LP, Coffin CM. Idiopathic fibrosclerotic disorders and other inflammatory pseudotumors. Semin Diagn Pathol. 1998;15:161-173.
125. Clark A, Zeman RK, Choyke PL, et al. Pancreatic pseudotumors associated with multifocal idiopathic fibrosclerosis. Gastrointest Radiol. 1988;13:30-32.
126. Waldram R, Kopelman H, Tsantoulas D, et al. Chronic pancreatitis, sclerosing cholangitis, and sicca complex in two siblings. Lancet. 1975;1:550-552.
127. Sjogren I, Wengle B, Korsgren M. Primary sclerosing cholangitis associated with fibrosis of the submandibular glands and the pancreas. Acta Med Scand. 1979;205:139-141.
128. Hamano H, Kawa S, Ochi Y, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet. 2002;359:1403-1404.
129. Fukukura Y, Fujiyoshi F, Nakamura F, et al. Autoimmune pancreatitis associated with idiopathic retroperitoneal fibrosis. AJR Am J Roentgenol. 2003;181:993-995.
130. Zen Y, Onodera M, Inoue D, et al. Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4. Am J Surg Pathol. 2009;33:1833-1839.
131. Chen TS, Montgomery EA. Are tumefactive lesions classified as sclerosing mesenteritis a subset of IgG4-related sclerosing disorders? J Clin Pathol. 2008;61:1093-1097.
132. Matsumoto Y, Kasashima S, Kawashima A, et al. A case of multiple immunoglobulin G4-related periarteritis: a tumorous lesion of the coronary artery and abdominal aortic aneurysm. Hum Pathol. 2008;39:975-980.
133. Sakata N, Tashiro T, Uesugi N, et al. IgG4-positive plasma cells in inflammatory abdominal aortic aneurysm: the possibility of an aortic manifestation of IgG4-related sclerosing disease. Am J Surg Pathol. 2008;32:553-559.
134. Qian Q, Kashani KB, Miller DV. Ruptured abdominal aortic aneurysm related to IgG4 periaortitis. N Engl J Med. 2009; 361:1121-1123.
135. Ito H, Kaizaki Y, Noda Y, et al. IgG4-related inflammatory abdominal aortic aneurysm associated with autoimmune pancreatitis. Pathol Int. 2008;58:421-426.
136. Ishida M, Hotta M, Kushima R, et al. IgG4-related inflammatory aneurysm of the aortic arch. Pathol Int. 2009; 59:269-273.
137. Stone JH, Khosroshahi A, Deshpande V, et al. IgG4-related systemic disease accounts for a significant proportion of thoracic lymphoplasmacytic aortitis cases. Arthritis Care Res (Hoboken). 2010;62:316-322.
138. Shrestha B, Sekiguchi H, Colby TV, et al. Distinctive pulmonary histopathology with increased IgG4-positive plasma cells in patients with autoimmune pancreatitis: report of 6 and 12 cases with similar histopathology. Am J Surg Pathol. 2009;33:1450-1462.
139. Zen Y, Inoue D, Kitao A, et al. IgG4-related lung and pleural disease: a clinicopathologic study of 21 cases. Am J Surg Pathol. 2009;33:1886-1893.
140. Kobayashi H, Shimokawaji T, Kanoh S, et al. IgG4-positive pulmonary disease. J Thorac Imaging. 2007;22:360-362.
141. Zen Y, Kasahara Y, Horita K, et al. Inflammatory pseudotumor of the breast in a patient with a high serum IgG4 level: histologic similarity to sclerosing pancreatitis. Am J Surg Pathol. 2005;29:275-278.
142. Takeda S, Haratake J, Kasai T, et al. IgG4-associated idiopathic tubulointerstitial nephritis complicating autoimmune pancreatitis. Nephrol Dial Transplant. 2004;19:474-476.
143. Watson SJ, Jenkins DA, Bellamy CO. Nephropathy in IgG4-related systemic disease. Am J Surg Pathol. 2006;30: 1472-1477.
144. Cornell LD, Chicano SL, Deshpande V, et al. Pseudotumors due to IgG4 immune-complex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease. Am J Surg Pathol. 2007;31:1586-1597.
145. Dhobale S, Bedetti C, Killian P, et al. IgG4 related sclerosing disease with multiple organ involvements and response to corticosteroid treatment. J Clin Rheumatol. 2009;15:354-357.
146. Uchiyama-Tanaka Y, Mori Y, Kimura T, et al. Acute tubulointerstitial nephritis associated with autoimmune- related pancreatitis. Am J Kidney Dis. 2004;43:e18-e25.
147. Saeki T, Nishi S, Ito T, et al. Renal lesions in IgG4-related systemic disease. Intern Med. 2007;46:1365-1371.
148. Kuroda N, Nakamura S, Miyazaki K, et al. Chronic sclerosing pyelitis with an increased number of IgG4-positive lasma cells. Med Mol Morphol. 2009;42:236-238.
149. Kim SA, Lee SR, Huh J, et al. IgG4-associated inflammatory pseudotumor of ureter: a report of three cases (Abstr). Mod Pathol. 2010;23(suppl 1):200A.
150. Sato Y, Kojima M, Takata K, et al. Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease. Mod Pathol. 2009;22: 589-599.
151. Wong S, Lam WY, Wong WK, et al. Hypophysitis presented as inflammatory pseudotumor in immunoglobulin G4-related systemic disease. Hum Pathol. 2007;38:1720-1723.
152. Tanabe T, Tsushima K, Yasuo M, et al. IgG4-associated multifocal systemic fibrosis complicating sclerosing sialadenitis, hypophysitis, and retroperitoneal fibrosis, but lacking pancreatic involvement. Intern Med. 2006;45:1243-1247.
153. Yamamoto M, Takahashi H, Ohara M, et al. A case of Mikulicz's disease (IgG4-related plasmacytic disease) complicated by autoimmune hypophysitis. Scand J Rheumatol. 2006; 35:410-411. (Pubitemid 44601080)
154. van der Vliet HJ, Perenboom RM. Multiple pseudotumors in IgG4-associated multifocal systemic fibrosis. Ann Intern Med. 2004;141:896-897.
155. Osawa S, Ogawa Y, Watanabe M, et al. Hypophysitis presenting with atypical rapid deterioration: with special reference to immunoglobulin G4-related disease-case report. Neurol Med Chir (Tokyo). 2009;49:622-625.
156. Shimatsu A, Oki Y, Fujisawa I, et al. Pituitary and stalk lesions (infundibulo-hypophysitis) associated with immuno- globulin G4-related systemic disease: an emerging clinical entity. Endocr J. 2009;56:1033-1041.
157. Hori M, Makita N, Andoh T, et al. Long-term clinical course of IgG4-related systemic disease accompanied by hypophysitis. Endocr J. 2010;57:485-492.
158. Chan SK, Cheuk W, Chan KT, et al. IgG4-related sclerosing achymeningitis: a previously unrecognized form of central nervous system involvement in IgG4-related sclerosing disease. Am J Surg Pathol. 2009;33:1249-1252.
159. Riku S, Kato S. Idiopathic hypertrophic pachymeningitis. Neuropathology. 2003;23:335-344.
160. Kupersmith MJ, Martin V, Heller G, et al. Idiopathic hypertrophic pachymeningitis. Neurology. 2004;62:686-694.
161. Lui PC, Fan YS, Wong SS, et al. Inflammatory pseudotumors of the central nervous system. Hum Pathol. 2009;40: 1611-1617.
162. Komatsu K, Hamano H, Ochi Y, et al. High prevalence of hypothyroidism in patients with autoimmune pancreatitis. DigDis Sci. 2005;50:1052-1057.
163. Li Y, Nishihara E, Hirokawa M, et al. Distinct clinical, serological, and sonographic characteristics of Hashimoto's thyroiditis based with and without IgG4-positive plasma cells. J Clin Endocrinol Metab. 2010;95:1309-1317.
164. Li Y, Bai Y, Liu Z, et al. Immunohistochemistry ofIgG4 can help subclassify Hashimoto's autoimmune thyroiditis. Pathol Int. 2009;59:636-641.
165. Drieskens O, Blockmans D, Van den Bruel A, et al. Riedel's thyroiditis and retroperitoneal fibrosis in multifocal fibro- sclerosis: positron emission tomographic findings. Clin Nucl Med. 2002;27:413-415.
166. Dahlgren M, Khosroshahi A, Nielsen GP, et al. Riedel's thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arthritis Care Res. 2010. [Epub ahead of print).
167. Zhang L, Smyrk TC. Autoimmune pancreatitis and IgG4-related systemic diseases. Int J Clin Exp Pathol. 2010;25: 491-504.
168. Yoshimura Y, Takeda S, Ieki Y, et al. IgG4-associated prostatitis complicating autoimmune pancreatitis. Intern Med. 2006;45:897-901.
169. Uehara T, Hamano H, Kawakami M, et al. Autoimmune pancreatitis-associated prostatitis: distinct clinicopathological entity. Pathol Int. 2008;58:118-125.
170. Nishimori I, Kohsaki T, Onishi S, et al. IgG4-related autoimmune prostatitis: two cases with or without autoimmune pancreatitis. Intern Med. 2007;46:1983-1989.
171. Taniguchi T, Kobayashi H, Fukui S, et al. A case of multifocal fibrosclerosis involving posterior mediastinal fibrosis, retroperitoneal fibrosis, and a left seminal vesicle with elevated serum IgG4. Hum Pathol. 2006;37:1237-1239; author reply 1239.
172. Ishida M, Hotta M, Kushima R, et al. Multiple IgG4-related sclerosing lesions in the maxillary sinus, parotid gland and nasal septum. Pathol Int. 2009;59:670-675.
173. Ikeda R, Awataguchi T, Shoji F, et al. A case of paranasal sinus lesions in IgG4-related sclerosing disease. Otolaryngol Head Neck Surg. 2010;142:458-459.
174. Sugimoto T, Morita Y, Isshiki K, et al. Constrictive pericarditis as an emerging manifestation of hyper-IgG4 disease. Int J Cardiol. 2008;130:e100-e101.
175. Fanburg-Smith JC, Lasota J, Auerbach A, et al. Tumors and tumor-like lesions of the soft tissues. In: Barnes L, ed. Surgical Pathology of the Head and Neck. 2 Vol. New York: Informa Healthcare; 2009:824-825.
176. Cheuk W, Tam FK, Chan AN, et al. Idiopathic cervical fibrosis: A new member of IgG4-related sclerosing diseases: Report of four cases, one complicated by composite lymphoma. Am J Surg Pathol. 2010. (In press).
177. Lopes J, Hochwald SN, Lancia N, et al. Autoimmune esophagitis: IgG4-related tumors of the esophagus. J Gastrointest Surg. 2010;14:1031-1034.
178. Martel M, Cheuk W, Lombardi L, et al. Sclerosing angiomatoid nodular transformation (SANT): report of 25 cases of a distinctive benign splenic lesion. Am J Surg Pathol. 2004;28:1268-1279.
179. Kashiwagi S, Kumasaka T, Bunsei N, et al. Detection of Epstein-Barr virus-encoded small RNA-expressed myofibroblasts and IgG4-producing plasma cells in sclerosing angiomatoid nodular transformation of the spleen. Virchows Arch. 2008;453:275-282.
180. Nagai Y, Hayama N, Kishimoto T, et al. Predominance of IgG4+ plasma cells and CD68 positivity in sclerosing angiomatoid nodular transformation (SANT). Histopathology. 2008;53:495-498.
181. Kojima M, Miyawaki S, Takada S, et al. Lymphoplasmacytic infiltrate of regional lymph nodes in Kuttner's tumor (chronic sclerosing sialadenitis): a report of 3 cases. Int J Surg Pathol. 2008;16:263-268.
182. Peterson BA, Frizzera G. Multicentric Castleman's disease. Semin Oncol. 1993;20:636-647.
183. Nishimoto N, Sasai M, Shima Y, et al. Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy. Blood. 2000;95:56-61.
184. Koo CH, Nathwani BN, Winberg CD, et al. Atypical lymphoplasmacytic and immunoblastic proliferation in lymph nodes of patients with autoimmune disease (autoimmunedisease-associated lymphadenopathy). Medicine (Baltimore). 1984;63:274-290.
185. Segal GH, Clough JD, Tubbs RR. Autoimmune and iatrogenic causes of lymphadenopathy. Semin Oncol. 1993;20: 611-626.
186. Kojima M, Nakamura S, Shimizu K, et al. Clinical implication of idiopathic plasmacytic lymphadenopathy with polyclonal hypergammaglobulinemia: a report of 16 cases. Int J Surg Pathol. 2004;12:25-30.
187. Aalberse RC, Van Milligen F, Tan KY, et al. Allergen-specific IgG4 in atopic disease. Allergy. 1993;48:559-569.
188. Shirakata Y, Shiraishi S, Sayama K, et al. Subclass characteristics of IgG autoantibodies in bullous pemphigoid and pemphigus. J Dermatol. 1990;17:661-666.
189. Kuo TT, Chen TC, Lee LY, et al. IgG4-positive plasma cells in cutaneous Rosai-Dorfman disease: an additional immunohistochemical feature and possible relationship to IgG4-related sclerosing disease. J Cutan Pathol. 2009.
190. Roberts SS, Attanoos RL. IgG4+ Rosai-Dorfman disease of the lung (Letter). Histopathology. 2010;56:662-664.
191. Shiomi T, Yoshida Y, Horie Y, et al. Acquired reactive perforating collagenosis with the histological features of IgG4-related sclerosing disease in a patient with Mikulicz's disease. Pathol Int. 2009;59:326-331.
192. Miyagawa-Hayashino A, Matsumura Y, Kawakami F, et al. High ratio of IgG4-positive plasma cell infiltration in cutaneous plasmacytosis-is this a cutaneous manifestation of IgG4-related disease? Hum Pathol. 2009;40:1269-1279.
193. Bedeir AS, Lash JG, Ray MB. IgG4+ plasma cells in gastric biopsies specific for patients with autoimmune atrophic gastritis/pernicious anemia (Abstr). Mod Pathol. 2010;23 (suppl 1):137A.
194. Tian W, Yakirevich EM A, Gnepp D. IgG4 positive plasma cells in sclerosing variant of mucoepidermoid carcinoma: a new and evolving concept (Abstr). Mod Pathol. 2010;23(suppl 1):281A.
195. Zen Y, Fujii T, Harada K, et al. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology. 2007;45: 1538-1546.
196. Chang MC, Chang YT, Wei SC, et al. Autoimmune pancreatitis associated with high prevalence of gastric ulcer independent of Helicobacter pylori infection status. Pancreas. 2009;38:442-446.
197. Kountouras J, Zavos C, Chatzopoulos D. A concept on the role of Helicobacter pylori infection in autoimmune pancreatitis. J Cell Mol Med. 2005;9:196-207.
198. Guarneri F, Guarneri C, Benvenga S. Helicobacter pylori and autoimmune pancreatitis: role of carbonic anhydrase viamolecular mimicry? J Cell Mol Med. 2005;9:741-744.
199. Okazaki K, Uchida K, Fukui T. Recent advances in autoimmune pancreatitis: concept, diagnosis, and pathogenesis. J Gastroenterol. 2008;43:409-418.
200. Koyabu M, Uchida K, Miyoshi H, et al. Analysis of regulatory T cells and IgG4-positive plasma cells among patients of IgG4-related sclerosing cholangitis and autoimmune liver diseases. J Gastroenterol. 2010;45:732-741.
201. Nakashima H, Miyake K, Moriyama M, et al. An amplification of IL-10 and TGF-beta in patients with IgG4-related tubulointerstitial nephritis. Clin Nephrol. 2010;73:385-391.
202. Frulloni L, Lunardi C, Simone R, et al. Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med. 2009;361:2135-2142.
203. Cheuk W, Yuen HK, Chan AC, et al. Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease. Am J Surg Pathol. 2008;32: 1159-1167.
204. Isaacson PG, Chott A, Nakamura S, et al. Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of S of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon: IARC; 2008: 214-217.
205. Takahashi N, Ghazale AH, Smyrk TC, et al. Possible association between IgG4-associated systemic disease with or without autoimmune pancreatitis and non-Hodgkin lymphoma. Pancreas. 2009;38:523-526.
206. Motosugi U, Ichikawa T, Yamaguchi H, et al. Small invasive ductal adenocarcinoma of the pancreas associated with lymphoplasmacytic sclerosing pancreatitis. Pathol Int. 2009; 59:744-747.
207. Witkiewicz AK, Kennedy EP, Kennyon L, et al. Synchronous autoimmune pancreatitis and infiltrating pancreatic ductal adenocarcinoma: case report and review of the literature. Hum Pathol. 2008;39:1548-1551.
208. Kamisawa T, Chen PY, Tu Y, et al. Pancreatic cancer with a high serum IgG4 concentration. World J Gastroenterol. 2006; 12:6225-6228.
209. Inoue H, Miyatani H, Sawada Y, et al. A case of pancreas cancer with autoimmune pancreatitis. Pancreas. 2006;33: 208-209.
210. Gupta RK, Geneway M, Johnson NB, et al. Is autoimmune pancreatitis associated with an increased risk of malignancy? A retrospective and comparative study (Abstr). Mod Pathol. 2010;23(suppl 1):356A.
211. Gill J, Angelo N, Yeong ML, et al. Salivary duct carcinoma arising in IgG4-related autoimmune disease of the parotid gland. Hum Pathol. 2009;40:881-886.
212. Joo M, Chang SH, Kim H, et al. Primary gastrointestinal clear cell sarcoma: report of 2 cases, one case associated with IgG4-related sclerosing disease, and review of literature. Ann Diagn Pathol. 2009;13:30-35.
213. Chan JK, Kwong YL. Common misdiagnoses in lymphomas and avoidance strategies. Lancet Oncol. 2010;11:579-588. 333-358